Table 3 Comparative studies involving chemoimmunotherapy and combinations of novel agents
Comparisons | Trial | Phase | Patients |
|---|---|---|---|
FCR vs I + V | NCT04010968 | 2 | TN CLL(fit) |
FCR/BR vs V + R vs V + O vs I + V + O | NCT02950051 | 3 | TN CLL(fit) |
FCR/BR vs A + V ± O | NCT03836261 | 3 | TN CLL |
I + V vs Chl + O | NCT03462719 | 3 | TN CLL/SLL |
I + O vs I + O + V | NCT03737981 | 3 | TN CLL/SLL(older) |
NCT03701282 | 3 | TN CLL/SLL(younger) | |
I vs I + V vs V + O | NCT04608318 | 3 | TN CLL |
A + V vs V + O | NCT05057494 | 3 | TN CLL/SLL |